Article Text

Download PDFPDF

Trigeminalepsy
  1. Carlos Miró1,
  2. Tomás Ortiz2
  1. 1 Department of Neuropsychiatry, University Hospital of La Ribera, Valencia, Spain
  2. 2 Magnetoencephalography Unit, Complutense University of Madrid, Madrid, Spain
  1. Correspondence to Dr Carlos Miró, Department of Neuropsychiatry, University Hospital of La Ribera, Carretera de Corbera Km. 1, Alzira, Valencia 46600, Spain; cmiro{at}hospital-ribera.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A 39-year-old-woman was admitted to the hospital after attempting to commit suicide by jumping off a bridge. She had been diagnosed with trigeminal neuralgia at the age of 19 years, which was refractory to medical therapy with carbamazepine and high doses of amitriptyline. She preferred to be self-medicated with benzodiazepines and alcohol to relieve her pain since she was 21 years old; nevertheless, such substance abuse led to impairment of depressive disorder induced by her rebel facial pain.

On admission, our patient fulfilled the criteria for major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-IV-TR; American Psychiatric Association, 2000), presenting with depressed …

View Full Text